{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:04:22Z","timestamp":1789448662596,"version":"build-2803163510"},"reference-count":18,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cytometry Part B Clinical"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Circulating tumor plasma cells (CTCs) at diagnosis are independent prognostic markers in newly diagnosed multiple myeloma (NDMM). Flow cytometry (FC) enables sensitive and cost\u2010effective CTC quantification, but prognostic cut\u2010offs vary across studies. The methodological approach used for quantification may affect the determination of the CTC percentage. In this study we compare head\u2010to\u2010head two FC techniques [single\u2010platform FC versus Next Generation Flow (NGF)] to measure CTC levels in NDMM patients. Methodological differences between the two techniques can be found in sample processing (NGF includes fixation and permeabilization steps that are not required for CTC quantification by single\u2010platform FC) and analytical sensitivity, which is higher for NGF than for single\u2010platform FC. The percentage of CTCs was simultaneously assessed with both techniques in the peripheral blood (PB) of 34 patients enrolled in the REAL MM trial (NCT03829371) at screening. Single\u2010platform FC detected CTCs in 29\/34 patients (85.3%) patients, while NGF detected CTCs in 31\/34 patients (91.2%), including 2 cases that were negative by single\u2010platform FC. The CTC percentage measured using the NGF technique (median 0.0049%, range 0%\u20130.377%) was significantly lower than that obtained using single\u2010platform FC (median 0.009%, range 0%\u20130.59%) (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.0001). Indeed, quantifying CTCs with FC after fixation and permeabilization (comparably to NGF) led to results that were similar to NGF. In conclusion, NGF demonstrated higher sensitivity than single\u2010platform FC to detect CTCs at diagnosis in MM patients. Employing standardized techniques like NGF may avoid variability across different laboratories and centers.\n                  <\/jats:p>","DOI":"10.1002\/cyto.b.70068","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T04:51:32Z","timestamp":1789447892000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Circulating tumor plasma cells quantification in newly diagnosed transplant ineligible real world multiple myeloma patients: Comparison of single\u2010platform flow cytometry versus next generation flow"],"prefix":"10.1002","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2275-9654","authenticated-orcid":false,"given":"Elona","family":"Saraci","sequence":"first","affiliation":[{"name":"Division of Hematology, University of Torino and Department of Molecular Biotechnology and Health Sciences University of Torino  Torino Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Larocca","sequence":"additional","affiliation":[{"name":"Division of Hematology, AOU Citt\u00e0 della Salute e della Scienza di Torino, University of Torino and Department of Molecular Biotechnology and Health Sciences University of Torino  Torino Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Ria","sequence":"additional","affiliation":[{"name":"Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe\u2010J) University of Bari Aldo Moro Medical School  Bari Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Mangiacavalli","sequence":"additional","affiliation":[{"name":"Division of Hematology IRCCS Fondazione Policlinico San Matteo  Pavia Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Benevolo","sequence":"additional","affiliation":[{"name":"SSD Clinical Trial in Oncoematologia e Mieloma Multiplo, Department of Oncology AOU Citt\u00e0 della Salute e della Scienza di Torino, University of Torino  Torino Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Giuliani","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina e Chirurgia Universit\u00e0 di Parma ed Ematologia AOU di Parma  Parma Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Zambello","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina (DIMED) Ematologia Universit\u00e0 di Padova  Padova Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Belotti","sequence":"additional","affiliation":[{"name":"Department of Hematology ASST Spedali Civili di Brescia  Brescia Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Rizzello","sequence":"additional","affiliation":[{"name":"IRCCS Azienda Ospedaliero\u2010Universitaria di Bologna, Istituto di Ematologia \u201cSer\u00e0gnoli\u201d, Bologna, Italy; Dipartimento di Scienze Mediche e Chirurgiche Universit\u00e0 di Bologna  Bologna Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonietta Pia","family":"Falcone","sequence":"additional","affiliation":[{"name":"Hematology, IRCCS \u201cCasa Sollievo della Sofferenza\u201d Hospital  San Giovanni Rotondo Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iolanda Donatella","family":"Vincelli","sequence":"additional","affiliation":[{"name":"Hematology Unit, Department of Hemato\u2010Oncology and Radiotherapy Grande Ospedale Metropolitano \u201cBianchi\u2010Melacrino\u2010Morelli\u201d  Reggio Calabria Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariagrazia","family":"Michieli","sequence":"additional","affiliation":[{"name":"U.O.S. Dip. Terapia Cellulare e Chemioterapia ad Alte Dosi, Centro di Riferimento Oncologico, IRCCS  Aviano Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Ronconi","sequence":"additional","affiliation":[{"name":"IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d  Meldola Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Tosi","sequence":"additional","affiliation":[{"name":"UO Ematologia, Ospedale di Rimini  Rimini Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria letizia Mosca","family":"Siez","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine Ospedale degli Infermi  Biella Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Allegra","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Human Pathology in Adulthood and Childhood \u201cGaetano Barresi\u201d University of Messina  Messina Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maide Maria","family":"Cavalli","sequence":"additional","affiliation":[{"name":"UOSD Ematologia, AULSS 6 Euganea, Osp., Camposampiero  Camposampiero (PD) Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilde","family":"Scaldaferri","sequence":"additional","affiliation":[{"name":"SC Farmacia Ospedaliera, AOU Citt\u00e0 della Salute e della Scienza di Torino  Torino Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Fedele","sequence":"additional","affiliation":[{"name":"Division of Hematology, University of Torino and Department of Molecular Biotechnology and Health Sciences University of Torino  Torino Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Burdisso","sequence":"additional","affiliation":[{"name":"Division of Hematology, University of Torino and Department of Molecular Biotechnology and Health Sciences University of Torino  Torino Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Villanova","sequence":"additional","affiliation":[{"name":"European Myeloma Network (EMN)  Torino Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Velluti","sequence":"additional","affiliation":[{"name":"European Myeloma Network (EMN)  Torino Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Capriata","sequence":"additional","affiliation":[{"name":"Haematology, Department of Translational and Precision Medicine Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome  Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donato","family":"Mannina","sequence":"additional","affiliation":[{"name":"UOC di Ematologia, Azienda Ospedaliera Papardo  Messina Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Cafro","sequence":"additional","affiliation":[{"name":"SC Ematologia, ASST GOM Niguarda  Milan Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Antonioli","sequence":"additional","affiliation":[{"name":"Hematology Unit, AOU Careggi  Florence Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Mor\u00e8","sequence":"additional","affiliation":[{"name":"Clinica di Ematologia, AOU delle Marche, Universit\u00e0 Politecnica delle Marche  Ancona Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Boccadoro","sequence":"additional","affiliation":[{"name":"European Myeloma Network (EMN)  Torino Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetto","family":"Bruno","sequence":"additional","affiliation":[{"name":"Division of Hematology, AOU Citt\u00e0 della Salute e della Scienza di Torino, University of Torino and Department of Molecular Biotechnology and Health Sciences University of Torino  Torino Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Bringhen","sequence":"additional","affiliation":[{"name":"Ematologia, ASO Santa Croce e Carle  Cuneo Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"D'Agostino","sequence":"additional","affiliation":[{"name":"Division of Hematology, AOU Citt\u00e0 della Salute e della Scienza di Torino, University of Torino and Department of Molecular Biotechnology and Health Sciences University of Torino  Torino Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/cyto.b.21606","article-title":"Increased circulating plasma cells detected by flow cytometry predicts poor prognosis in patients with plasma cell myeloma","volume":"94","author":"Bae M. H.","year":"2018","journal-title":"Cytometry Part B: Clinical Cytometry"},{"issue":"27","key":"e_1_2_7_3_1","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1200\/JCO.21.01393","article-title":"High levels of circulating tumor plasma cells as a key Hallmark of aggressive disease in transplant\u2010eligible patients with newly diagnosed multiple myeloma","volume":"40","author":"Bertamini L.","year":"2022","journal-title":"Journal of Clinical Oncology"},{"key":"e_1_2_7_4_1","unstructured":"Bertamini L. \u017dihala D. Kostopoulos I. et al. (2025).Circulating Tumor Cells for the staging of Multiple Myeloma: A European pooled analysis of 2446 newly diagnosed patients. (Abstract: S199); EHA 2025 Milan Italy."},{"issue":"7","key":"e_1_2_7_5_1","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1182\/blood.2023022080","article-title":"Predictors of unsustained measurable residual disease negativity in patients with multiple myeloma","volume":"143","author":"D'Agostino M.","year":"2024","journal-title":"Blood"},{"key":"e_1_2_7_6_1","doi-asserted-by":"crossref","unstructured":"D'Agostino M. Bringhen S. Piciocchi A. et al. (2025).Bortezomib\u2010melphalan\u2010prednisone (VMP) +\/\u2212 daratumumab (DVMP) vs. lenalidomidedexamethasone (Rd) +\/\u2212 daratumumab (DRd) in transplant\u2010ineligible real\u2010life multiple myeloma patients: Results from the randomized phase IV real MM trial. (Abstract: 6356); ASH 2025 Orlando Florida.","DOI":"10.1182\/blood-2025-6356"},{"issue":"10","key":"e_1_2_7_7_1","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1038\/leu.2017.29","article-title":"Next generation flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma","volume":"31","author":"Flores\u2010Montero J.","year":"2017","journal-title":"Leukemia"},{"issue":"27","key":"e_1_2_7_8_1","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1200\/JCO.21.01365","article-title":"Circulating tumor cells for the staging of patients with newly diagnosed transplant\u2010eligible multiple myeloma","volume":"40","author":"Garc\u00e9s J. J.","year":"2022","journal-title":"Journal of Clinical Oncology"},{"issue":"7","key":"e_1_2_7_9_1","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1182\/blood.2023022083","article-title":"Predictors of unsustained measurable residual disease negativity in transplant\u2010eligible patients with multiple myeloma","volume":"143","author":"Guerrero C.","year":"2024","journal-title":"Blood"},{"key":"e_1_2_7_10_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.currproblcancer.2023.101025","article-title":"Detection of circulating normal and tumor plasma cells in newly diagnosed patients of multiple myeloma and their associations with clinical and laboratory parameters","volume":"48","author":"Gupta L.","year":"2024","journal-title":"Current Problems in Cancer"},{"key":"e_1_2_7_11_1","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1080\/16078454.2021.1948208","article-title":"Prognostic value of circulating plasma cells detected by flow cytometry in newly diagnosed multiple myeloma patients","volume":"26","author":"Han W.","year":"2021","journal-title":"Hematology"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01606"},{"issue":"2","key":"e_1_2_7_13_1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/cyto.b.22149","article-title":"An alternative processing approach to increase CD138 intensity in flow cytometric analysis of plasma cells","volume":"106","author":"Kumar D.","year":"2024","journal-title":"Cytometry. Part B, Clinical Cytometry"},{"issue":"7","key":"e_1_2_7_14_1","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1080\/10428194.2016.1250263","article-title":"Plasma cell leukemia: Update on biology and therapy","volume":"58","author":"Mina R.","year":"2017","journal-title":"Leukemia & Lymphoma"},{"issue":"6","key":"e_1_2_7_15_1","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.3390\/cancers12061499","article-title":"Detection of circulating tumor plasma cells in monoclonal Gammopathies: Methods, pathogenic role, and clinical implications","volume":"12","author":"Sanoja\u2010Flores L.","year":"2020","journal-title":"Cancers"},{"issue":"12","key":"e_1_2_7_16_1","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1007\/s00277-021-04634-5","article-title":"Minimal residual disease detection in multiple myeloma: Comparison between BML single\u2010tube 10\u2010color multiparameter flow cytometry and EuroFlow multiparameter flow cytometry","volume":"100","author":"Sato K.","year":"2021","journal-title":"Annals of Hematology"},{"issue":"3","key":"e_1_2_7_17_1","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14030473","article-title":"Impact of pre\u2010analytical and analytical variables associated with sample preparation on flow cytometric Stainings obtained with EuroFlow panels","volume":"14","author":"Sedek L.","year":"2022","journal-title":"Cancers"},{"issue":"4","key":"e_1_2_7_18_1","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s12185-019-02615-z","article-title":"Comparison of minimal residual disease detection in multiple myeloma by SRL 8\u2010color single\u2010tube and EuroFlow 8\u2010color 2\u2010tube multiparameter flow cytometry","volume":"109","author":"Takamatsu H.","year":"2019","journal-title":"International Journal of Hematology"},{"key":"e_1_2_7_19_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2022.113379","article-title":"Comparative flow cytometry\u2010based immunophenotyping analysis of peripheral blood leukocytes before and after fixation with paraformaldehyde","volume":"511","author":"Vistica Sampino E.","year":"2022","journal-title":"Journal of Immunological Methods"}],"container-title":["Cytometry Part B: Clinical Cytometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cyto.b.70068","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cyto.b.70068","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cyto.b.70068","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T04:51:51Z","timestamp":1789447911000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/cyto.b.70068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":18,"alternative-id":["10.1002\/cyto.b.70068"],"URL":"https:\/\/doi.org\/10.1002\/cyto.b.70068","archive":["Portico"],"relation":{},"ISSN":["1552-4949","1552-4957"],"issn-type":[{"value":"1552-4949","type":"print"},{"value":"1552-4957","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,14]]},"assertion":[{"value":"2026-03-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"cyto.b.70068"}}